Special Drug Use-results Survey for Long-term Use（Avacopan）
NCT06758271 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2025-01-17
Summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Conditions
- Microscopic Polyangiitis (MPA)
- Granulomatosis With Polyangiitis (GPA)
Interventions
- DRUG
-
Avacopan
oral administration
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-29
- Primary Completion
- 2028-05-31
- Completion
- 2028-05-31
Countries
- Japan
More Related Trials
-
Evaluation of Anti-neutrophil Cytoplasm Antibodies Test
NCT04719715 ·Status: UNKNOWN
-
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
NCT04944524 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
NCT03192969 ·Status: WITHDRAWN ·Phase: PHASE3
-
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
NCT01559155 ·Status: TERMINATED
-
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
NCT00400075 ·Status: UNKNOWN ·Phase: PHASE4
-
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
NCT02807103 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
NCT02994927 ·Status: COMPLETED ·Phase: PHASE3
-
Giant Cell Arteritis - Ways to Precision Medicine
NCT07084480 ·Status: RECRUITING
-
Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis
NCT03782870 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
NCT04871191 ·Status: RECRUITING ·Phase: PHASE3
-
An Exploratory Study of MT-2990 in Patients With AAV
NCT06196905 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
NCT06868290 ·Status: RECRUITING ·Phase: PHASE2
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
NCT00647166 ·Status: COMPLETED ·Phase: PHASE3
-
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
NCT02108860 ·Status: COMPLETED ·Phase: PHASE3
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
NCT03688490 ·Status: COMPLETED
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
International Registry for Patients With Castleman Disease
NCT02817997 ·Status: RECRUITING
-
Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
NCT01265082 ·Status: UNKNOWN